Executive Summary
The June 24, 2026 insider trading digest reveals a pronounced bearish tilt, with 11 open-market sales versus only 6 open-market purchases, a ratio of nearly 2:1.
The most significant insider activity is concentrated in the biotechnology and technology sectors, where multiple C-suite executives at Relay Therapeutics, Maze Therapeutics, and Twist Bioscience executed large, pre-planned sales, often following option exercises that locked in substantial gains. However, a notable contrarian signal emerges from American Shared Hospital Services, where the Executive Chairman made a massive $1.34M open-market purchase, signaling strong conviction at a depressed price. The day was also marked by a wave of equity awards (18 filings) and option dispositions related to corporate actions at Centessa Pharmaceuticals, which are neutral events but highlight significant insider holdings. Overall, the data suggests a cautious posture among corporate insiders, particularly in high-growth names, while select value-oriented purchases offer potential alpha opportunities.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior Insider Trading Pulse digest from June 23, 2026.
Investment Signals (12)
- American Shared Hospital Services ↓ (BULLISH)▲
Executive Chairman Stachowiak Raymond C bought 586,468 shares at $2.28 (~$1.34M), a massive open-market purchase representing a 100% increase in his position. This is a strong vote of confidence from the highest insider at a micro-cap company.
- Relay Therapeutics ↓ (BEARISH)▲
CFO Catinazzo Thomas sold 61,563 shares (~$1.04M) and President of R&D Bergstrom Donald A sold 93,456 shares (~$1.58M), both under Rule 10b5-1 plans. The sales follow option exercises at ~$4-5, realizing massive profits (3-4x cost basis). The sheer volume of insider selling from two top executives is a significant bearish signal.
- Riot Platforms ↓ (BEARISH)▲
CEO Les Jason sold 62,703 shares at $30.09 (~$1.89M) under a 10b5-1 plan. This is a substantial sale by the top executive of a leading Bitcoin miner, potentially signaling a peak in the stock or a need for personal liquidity.
- Rhythm Pharmaceuticals ↓ (BEARISH)▲
Director TETRAULT LYNN A. sold 37,000 shares at $100.32 (~$3.71M) after exercising options at $28.27. This is a large, profitable sale by a director, suggesting the stock may be fully valued near its highs.
- Dell Technologies ↓ (BEARISH)▲
Director Radakovich Lynn Vojvodich sold 12,022 shares at $421.00 (~$5.06M) after exercising options at $31.14. This is a significant sale by a director at a high stock price, locking in a massive gain.
- Carlyle Tactical Private Credit Fund ↓ (BULLISH)▲
THRIVENT FINANCIAL FOR LUTHERANS bought 200,000 Mandatory Redeemable Preferred Shares, Series M at $25.00 (~$5M). This is a large institutional purchase of a preferred security, indicating strong demand for yield.
- Clean Energy Fuels Corp ↓ (BULLISH)▲
CEO Corbus Barclay bought 14,000 shares at $1.77 (~$24.8K). An open-market purchase by the CEO at a low stock price is a bullish signal for this alternative energy play.
- Seaport Therapeutics ↓ (BULLISH)▲
Director HOMBACH ROBERT J. bought 13,000 shares at $18.14 (~$236K). A significant open-market purchase by a director in a biotech firm is a strong vote of confidence.
- Maze Therapeutics ↓ (BEARISH)▲
CEO Coloma Jason V sold 23,865 shares at $26.05 (~$622K) under a 10b5-1 plan. This is a large sale by the CEO, which is bearish, especially given the stock's price level.
- Twist Bioscience Corp ↓ (BEARISH)▲
CEO Leproust Emily M. sold 1,688 shares at $87.32 (~$147K), while two other officers (SVP HR and SVP) also sold small amounts at the same price. This coordinated selling, though small in value, is a bearish signal from the top executive.
- NewAmsterdam Pharma ↓ (BEARISH)▲
CAO Kooij Louise Frederika sold 39,700 shares at $30.20 (~$1.2M) after exercising options at ~$11. This is a large, profitable sale by a key financial officer, suggesting the stock may be near a peak.
- Presurance Holdings ↓ (BULLISH)▲
10% owner Clarkston Companies acquired 1,600 Series D Preferred Stock at $5,000 (~$8M) while disposing of an equal amount of Series C Preferred. This is a roll-up into a new security, a neutral to positive signal of continued institutional support.
Risk Flags (10)
- Relay Therapeutics / Insider Selling↓ [HIGH RISK]▼
CFO and President of R&D sold a combined ~$2.6M in stock after option exercises. This is a major red flag for investor sentiment, as it shows top management is cashing out significant equity.
- Rhythm Pharmaceuticals / Director Sale↓ [HIGH RISK]▼
Director TETRAULT sold 84% of her holdings (37,000 of 44,000 shares post-exercise) for ~$3.71M. This near-total exit by a director is a strong negative signal.
- Dell Technologies / Director Sale↓ [MODERATE RISK]▼
Director Radakovich sold 32% of her holdings (12,022 of 37,289 shares) for ~$5.06M. A large sale by a director at a high price is a risk flag.
- Riot Platforms / CEO Sale↓ [MODERATE RISK]▼
CEO Les Jason sold 62,703 shares for ~$1.89M. While under a 10b5-1 plan, the size of the sale relative to his holdings is notable and could pressure the stock.
- Maze Therapeutics / CEO Sale↓ [MODERATE RISK]▼
CEO Coloma Jason V sold 23,865 shares for ~$622K. This is a significant sale by the CEO of a clinical-stage biotech, which may concern investors about the company's near-term prospects.
- NewAmsterdam Pharma / CAO Sale↓ [MODERATE RISK]▼
CAO Kooij sold 62% of her post-exercise holdings (39,700 of 64,053 shares) for ~$1.2M. This is a substantial reduction by a key insider.
- Twist Bioscience Corp / Multiple Insider Sales↓ [MODERATE RISK]▼
CEO and two other officers sold stock on the same day at the same price ($87.32). This coordinated selling, even if small, is a risk flag for management sentiment.
- VICOR CORP / Director Sale↓ [HIGH RISK]▼
Director D'Amico Andrew sold 300 shares at $357.47 (~$107K) after exercising options, reducing his holdings to just 100 shares. This near-complete exit is a strong negative signal.
- Omada Health / CFO Sale↓ [MODERATE RISK]▼
CFO Cook Steven L. sold 17,950 shares for ~$325K under a 10b5-1 plan. A significant sale by the CFO is a risk flag for a company in the digital health space.
- Zai Lab / Director Sale↓ [MODERATE RISK]▼
Director Lis William sold 7,040 ADS for ~$127K under a 10b5-1 plan. This is a notable sale by a director of a China-based biotech, adding to the bearish sentiment in the sector.
Opportunities (9)
- American Shared Hospital Services / Insider Conviction↓ (OPPORTUNITY)◆
Executive Chairman's $1.34M open-market purchase at $2.28 is a massive vote of confidence. This micro-cap company could be a turnaround story, and the insider's action suggests significant undervaluation.
- ◆
A $5M institutional purchase of preferred shares at $25.00 signals strong demand for yield. This could be a stable income opportunity with institutional backing.
- Clean Energy Fuels Corp / CEO Purchase↓ (OPPORTUNITY)◆
CEO's $24.8K open-market purchase at $1.77 is a bullish signal from the top executive. The stock is at a low price, and the purchase could indicate a near-term catalyst.
- Seaport Therapeutics / Director Purchase↓ (OPPORTUNITY)◆
Director's $236K open-market purchase at $18.14 is a strong signal for this biotech. The purchase suggests confidence in the company's pipeline or upcoming catalysts.
- Carlyle Credit Income Fund / Insider Purchase↓ (OPPORTUNITY)◆
PFO, PAO & Treasurer Joseph Nelson bought 2,000 shares at $2.73 (~$5.46K). This is a small but positive signal from a financial officer, indicating the stock may be undervalued.
- Lifeloc Technologies / CEO Purchase↓ (OPPORTUNITY)◆
CEO and President Willkomm Wayne bought 1,300 shares at $2.50 (~$3.25K). A small open-market purchase by the CEO of a micro-cap is a bullish signal.
- Presurance Holdings / Institutional Roll-Up↓ (OPPORTUNITY)◆
10% owner Clarkston Companies invested $8M in new Series D Preferred, showing continued institutional support. This could be a prelude to a positive corporate development.
- BEXIL INVESTMENT TRUST / Insider Accumulation↓ (OPPORTUNITY)◆
WINMILL & CO. INC bought 2,135 shares at ~$16.80 (~$35.8K). This is a small but consistent accumulation by a 10% owner, suggesting value.
- FVCBankcorp / Insider Purchase↓ (OPPORTUNITY)◆
Sr EVP, Chief Credit Officer Nassy Michael G. had shares withheld for taxes, a neutral event, but the bank's insider activity is otherwise quiet. This could be a value play in the regional banking space.
Sector Themes (6)
- Biotech Insider Profit-Taking (BEARISH)◆
A clear theme of insider selling in the biotech sector, with executives at Relay Therapeutics, Rhythm Pharmaceuticals, Maze Therapeutics, and NewAmsterdam Pharma all selling large blocks of stock after option exercises. This suggests that insiders view current valuations as attractive for cashing out, which could signal a sector peak.
- Tech Insider Caution (BEARISH)◆
Insiders at high-growth tech companies like Twist Bioscience, Dell Technologies, and Riot Platforms are selling stock, indicating a cautious outlook. This is a contrarian signal to the broader market optimism in tech.
- Value/Micro-Cap Insider Buying (BULLISH)◆
A counter-trend of insider buying is emerging in micro-cap and value-oriented names like American Shared Hospital Services, Clean Energy Fuels, and Lifeloc Technologies. This suggests that insiders see deep value in these beaten-down stocks.
- Institutional Demand for Yield (BULLISH)◆
The $5M purchase of preferred shares in Carlyle Tactical Private Credit Fund and the $8M investment in Presurance Holdings' preferred stock highlight strong institutional demand for yield-generating securities. This is a positive signal for the credit and preferred stock market.
- Equity Awards as a Retention Tool (NEUTRAL)◆
A large number of filings (18) were equity awards (RSUs, stock options) to directors and officers. This is a neutral signal but indicates companies are using equity to retain key talent, which is common in growth and turnaround situations.
- Centessa Pharmaceuticals Corporate Action (NEUTRAL)◆
Multiple insiders (CLO, Directors) disposed of shares and options to the issuer, likely as part of a corporate restructuring or buyback. This is a neutral event but highlights significant insider holdings being unwound, which could be a precursor to a larger transaction.
Watch List (8)
-
Watch for further insider selling or a change in guidance. The CFO and President of R&D have sold significant shares, and any negative news could accelerate the sell-off. [Earnings Call: TBD]
-
Monitor the stock price following the Executive Chairman's massive purchase. If the stock remains depressed, it could be a strong buy signal. [No upcoming events]
-
Watch for any commentary from CEO Les Jason on Bitcoin production or hash rate following his large stock sale. [Earnings Call: TBD]
-
Monitor for any clinical data readouts or regulatory updates following the director's large sale. [Earnings Call: TBD]
-
Watch for any changes in the company's outlook or capital allocation strategy following the director's sale. [Earnings Call: TBD]
-
Monitor for any insider buying to offset the recent selling by the CEO and other officers. [Earnings Call: TBD]
-
Watch for a formal announcement regarding the insider share dispositions, which could be related to a buyback, merger, or other corporate action. [No upcoming events]
-
Monitor for details on the new Series D Preferred Stock and the company's capital plans following the $8M investment. [No upcoming events]
Filing Analyses
(50)
24-06-2026
Director IP WING WAI was awarded 1,000 Class A ordinary shares, par value $0.001 per share. IP WING WAI holds 2,000 shares after the transaction.
- · Director IP WING WAI was awarded 1,000 Class A ordinary shares, par value $0.001 per share
- · Director IP WING WAI was awarded 1,000 Restricted Stock Units
24-06-2026
Director HOMBACH ROBERT J. bought 13,000 Common Stock at $18.14 (~$236K). HOMBACH ROBERT J. holds 13,000 shares after the transaction.
- · Director HOMBACH ROBERT J. bought 13,000 Common Stock at $18.14 (~$236K)
24-06-2026
Director Xu Yifang was awarded 1,000,000 Class A ordinary shares. Xu Yifang holds 6,454,776 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Xu Yifang was awarded 1,000,000 Class A ordinary shares
24-06-2026
Group head of Technology Wang Zhe (Maik) was awarded 160,000 Class A ordinary shares. Wang Zhe (Maik) holds 160,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Group head of Technology Wang Zhe (Maik) was awarded 160,000 Class A ordinary shares
24-06-2026
VP Chuang Tzu-Sou gifted 500,000 Common Shares (2330.TW). Chuang Tzu-Sou holds 1,495,165 shares after the transaction.
- · VP Chuang Tzu-Sou gifted 500,000 Common Shares (2330.TW)
24-06-2026
Chief financial officer Fan Chunlin was awarded 240,000 Class A ordinary shares. Fan Chunlin holds 1,802,152 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief financial officer Fan Chunlin was awarded 240,000 Class A ordinary shares
24-06-2026
CFO and COO Jiang Jun Jason sold 2 American depositary shares at $0.24 (~$0.48). Jiang Jun Jason holds 2,798,032 shares after the transaction.
- · CFO and COO Jiang Jun Jason sold 2 American depositary shares at $0.24 (~$0.48)
24-06-2026
Director Levy Elliott M. disposed to the issuer 23,811,896 Options.
- · Director Levy Elliott M. disposed to the issuer 23,811,896 Options
24-06-2026
Chief Executive Officer Qiu Wenbin bought 10,000 American Depositary Shares at $2.81 (~$28.1K). Qiu Wenbin holds 1,623,872 shares after the transaction.
- · Chief Executive Officer Qiu Wenbin bought 10,000 American Depositary Shares at $2.81 (~$28.1K)
24-06-2026
Director Holden Stuart was awarded 20,000 Stock Option (right ot buy).
- · Director Holden Stuart was awarded 20,000 Stock Option (right ot buy)
24-06-2026
THRIVENT FINANCIAL FOR LUTHERANS bought 200,000 Mandatory Redeemable Preferred Shares, Series M at $25.00 (~$5M). THRIVENT FINANCIAL FOR LUTHERANS holds 200,000 shares after the transaction.
- · THRIVENT FINANCIAL FOR LUTHERANS bought 200,000 Mandatory Redeemable Preferred Shares, Series M at $25.00 (~$5M)
24-06-2026
PRESIDENT AND CEO Corbus Barclay bought 14,000 Common Stock at $1.77 (~$24.8K). Corbus Barclay holds 1,350,021 shares after the transaction.
- · PRESIDENT AND CEO Corbus Barclay bought 14,000 Common Stock at $1.77 (~$24.8K)
24-06-2026
Director D'Amico Andrew sold 300 Common Stock at $357.47 (~$107K). 10 transactions reported in total. D'Amico Andrew holds 100 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director D'Amico Andrew exercised/converted 1,216 Common Stock at $32.89 (~$40K)
- · Director D'Amico Andrew sold 100 Common Stock at $354.12 (~$35.4K)
- · Director D'Amico Andrew sold 300 Common Stock at $357.47 (~$107K)
- · Director D'Amico Andrew sold 200 Common Stock at $359.05 (~$71.8K)
- · Director D'Amico Andrew sold 200 Common Stock at $362.13 (~$72.4K)
- · Director D'Amico Andrew sold 200 Common Stock at $363.33 (~$72.7K)
- · Director D'Amico Andrew sold 116 Common Stock at $365.84 (~$42.4K)
- · Director D'Amico Andrew sold 100 Common Stock at $367.10 (~$36.7K)
24-06-2026
Director Jerman Michael Allen was awarded 50,000 Common Stock. Jerman Michael Allen holds 180,411 shares after the transaction.
- · Director Jerman Michael Allen was awarded 50,000 Common Stock
24-06-2026
Chief Operating Officer Frabotta Bartolomeo A. was awarded 50,000 Common Stock. Frabotta Bartolomeo A. holds 512,886 shares after the transaction.
- · Chief Operating Officer Frabotta Bartolomeo A. was awarded 50,000 Common Stock
24-06-2026
Chief Accounting Officer Kooij Louise Frederika sold 39,700 Ordinary Shares at $30.20 (~$1.2M). 6 transactions reported in total. Kooij Louise Frederika holds 24,353 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Accounting Officer Kooij Louise Frederika exercised/converted 25,000 Ordinary Shares at $10.90 (~$273K)
- · Chief Accounting Officer Kooij Louise Frederika exercised/converted 15,000 Ordinary Shares at $11.90 (~$179K)
- · Chief Accounting Officer Kooij Louise Frederika sold 39,700 Ordinary Shares at $30.20 (~$1.2M)
- · Chief Accounting Officer Kooij Louise Frederika sold 300 Ordinary Shares at $30.73 (~$9.22K)
- · Chief Accounting Officer Kooij Louise Frederika exercised/converted 25,000 Option (right to buy)
- · Chief Accounting Officer Kooij Louise Frederika exercised/converted 15,000 Option (right to buy)
24-06-2026
Director Lefebvre d'Ovidio Manfredi sold 492 Business Combination Warrants (right to buy) at $1.80 (~$886).
- · Director Lefebvre d'Ovidio Manfredi sold 120 Business Combination Warrants (right to buy) at $1.40 (~$168)
- · Director Lefebvre d'Ovidio Manfredi sold 492 Business Combination Warrants (right to buy) at $1.80 (~$886)
24-06-2026
Director Lis William sold 7,040 American Depositary Shares at $18.09 (~$127K). Lis William holds 50,437 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Lis William sold 7,040 American Depositary Shares at $18.09 (~$127K)
24-06-2026
Chief Executive Officer Leproust Emily M. sold 1,688 Common Stock at $87.32 (~$147K). Leproust Emily M. holds 842,919 shares after the transaction.
- · Chief Executive Officer Leproust Emily M. sold 1,688 Common Stock at $87.32 (~$147K)
24-06-2026
CEO, Chairman of the Board STERNLICHT BARRY S disposed of 4,182 Common Stock. STERNLICHT BARRY S holds 3,285,058 shares after the transaction.
- · CEO, Chairman of the Board STERNLICHT BARRY S disposed of 4,182 Common Stock
24-06-2026
Director Amouyal Philippe was awarded 1,881 Common Stock. Amouyal Philippe holds 19,955 shares after the transaction.
- · Director Amouyal Philippe was awarded 1,881 Common Stock
24-06-2026
Director Felt Benjamin was awarded 1,881 Common Stock. Felt Benjamin holds 9,955 shares after the transaction.
- · Director Felt Benjamin was awarded 1,881 Common Stock
24-06-2026
10% owner Tai Wey Ann reported beneficial ownership in Aditxt, Inc.. 1 position reported.
- · Holds 100,000 Common Stock, $0.001 par value (direct)
24-06-2026
Chief Financial Officer Cook Steven L. sold 17,950 Common Stock at $18.13 (~$325K). Cook Steven L. holds 169,259 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Financial Officer Cook Steven L. sold 17,950 Common Stock at $18.13 (~$325K)
24-06-2026
EVP and CFO Farag Andrew was awarded 28,843 Restricted Stock Units.
- · EVP and CFO Farag Andrew was awarded 28,843 Restricted Stock Units
24-06-2026
Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 117,645 Ordinary Shares. 10 transactions reported in total.
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 117,645 Ordinary Shares
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 5,500 Ordinary Shares
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 221,559 Share Option (right to buy)
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 166,779 Share Option (right to buy)
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 100,000 Share Option (right to buy)
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 160,000 Share Option (right to buy)
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 100,000 Share Option (right to buy)
- · Chief Legal Officer HUSSAIN IQBAL J disposed to the issuer 170,000 Share Option (right to buy)
24-06-2026
Director De Rubertis Francesco disposed to the issuer 4,398,519 Ordinary Shares. 6 transactions reported in total.
- · Director De Rubertis Francesco disposed to the issuer 4,398,519 Ordinary Shares
- · Director De Rubertis Francesco disposed to the issuer 55,677 Ordinary Shares
- · Director De Rubertis Francesco disposed to the issuer 3,936,970 Ordinary Shares
- · Director De Rubertis Francesco disposed to the issuer 93,526 Ordinary Shares
- · Director De Rubertis Francesco disposed to the issuer 11,197,303 Ordinary Shares
- · Director De Rubertis Francesco disposed to the issuer 281,162 Ordinary Shares
24-06-2026
Director Hukkelhoven Mathias disposed to the issuer 96,000 Share Option (right to buy). 4 transactions reported in total.
- · Director Hukkelhoven Mathias disposed to the issuer 96,000 Share Option (right to buy)
- · Director Hukkelhoven Mathias disposed to the issuer 48,000 Share Option (right to buy)
- · Director Hukkelhoven Mathias disposed to the issuer 48,000 Share Option (right to buy)
- · Director Hukkelhoven Mathias disposed to the issuer 40,000 Share Option (right to buy)
24-06-2026
Director ZBAR BRETT I W disposed to the issuer 64,570 Share Option (right to buy). 5 transactions reported in total.
- · Director ZBAR BRETT I W disposed to the issuer 64,570 Share Option (right to buy)
- · Director ZBAR BRETT I W disposed to the issuer 48,000 Share Option (right to buy)
- · Director ZBAR BRETT I W disposed to the issuer 48,000 Share Option (right to buy)
- · Director ZBAR BRETT I W disposed to the issuer 48,000 Share Option (right to buy)
- · Director ZBAR BRETT I W disposed to the issuer 40,000 Share Option (right to buy)
24-06-2026
Director TETRAULT LYNN A. sold 37,000 Common Stock at $100.32 (~$3.71M). TETRAULT LYNN A. holds 7,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director TETRAULT LYNN A. exercised/converted 37,000 Common Stock at $28.27 (~$1.05M)
- · Director TETRAULT LYNN A. sold 37,000 Common Stock at $100.32 (~$3.71M)
- · Director TETRAULT LYNN A. exercised/converted 37,000 Stock Option (right to buy)
24-06-2026
CEO Les Jason sold 62,703 Common Stock at $30.09 (~$1.89M). Les Jason holds 1,263,556 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CEO Les Jason sold 62,703 Common Stock at $30.09 (~$1.89M)
24-06-2026
Director NATELLI THOMAS A was awarded 1,814 Common Stock. NATELLI THOMAS A holds 228,393 shares after the transaction.
- · Director NATELLI THOMAS A was awarded 1,814 Common Stock
24-06-2026
Chief Executive Officer Coloma Jason V sold 23,865 Common Stock at $26.05 (~$622K). Coloma Jason V holds 319,079 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Executive Officer Coloma Jason V sold 1,953 Common Stock at $26.00 (~$50.8K)
- · Chief Executive Officer Coloma Jason V sold 2,040 Common Stock at $26.00 (~$53K)
- · Chief Executive Officer Coloma Jason V sold 23,865 Common Stock at $26.05 (~$622K)
24-06-2026
10% owner BROWN ROBERT G/ gifted 4,000 Common Stock, $.01 par value. BROWN ROBERT G/ holds 2,877,389 shares after the transaction.
- · 10% owner BROWN ROBERT G/ gifted 4,000 Common Stock, $.01 par value
24-06-2026
Director Fleming Katherine E. was awarded 8,500 Common Stock. Fleming Katherine E. holds 44,028 shares after the transaction.
- · Director Fleming Katherine E. was awarded 8,500 Common Stock
24-06-2026
Chief Legal Officer Smith Michael Alexander sold 1,806 Common Stock at $95.82 (~$173K). Smith Michael Alexander holds 37,648 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Legal Officer Smith Michael Alexander sold 1,806 Common Stock at $95.82 (~$173K)
24-06-2026
PFO, PAO & Treasurer Joseph Nelson bought 2,000 Common Stock at $2.73 (~$5.46K). Joseph Nelson holds 5,700 shares after the transaction.
- · PFO, PAO & Treasurer Joseph Nelson bought 2,000 Common Stock at $2.73 (~$5.46K)
24-06-2026
CEO and President Willkomm Wayne bought 1,300 Common Stock at $2.50 (~$3.25K). Willkomm Wayne holds 41,625 shares after the transaction.
- · CEO and President Willkomm Wayne bought 1,300 Common Stock at $2.50 (~$3.25K)
24-06-2026
Sr EVP, Chief Credit Officer Nassy Michael G. had withheld for taxes 656 Common Stock at $17.24 (~$11.3K). Nassy Michael G. holds 62,534 shares after the transaction.
- · Sr EVP, Chief Credit Officer Nassy Michael G. had withheld for taxes 656 Common Stock at $17.24 (~$11.3K)
24-06-2026
Director Radakovich Lynn Vojvodich sold 12,022 Class C Common Stock at $421.00 (~$5.06M). Radakovich Lynn Vojvodich holds 25,267 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Radakovich Lynn Vojvodich exercised/converted 12,022 Class C Common Stock at $31.14 (~$374K)
- · Director Radakovich Lynn Vojvodich sold 12,022 Class C Common Stock at $421.00 (~$5.06M)
- · Director Radakovich Lynn Vojvodich exercised/converted 12,022 Options to Acquire Class C Common Stock
24-06-2026
Chief Financial Officer Catinazzo Thomas sold 61,563 Common Stock at $16.97 (~$1.04M). 10 transactions reported in total. Catinazzo Thomas holds 177,461 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Financial Officer Catinazzo Thomas sold 17,717 Common Stock at $17.01 (~$301K)
- · Chief Financial Officer Catinazzo Thomas exercised/converted 56,323 Common Stock at $5.04 (~$284K)
- · Chief Financial Officer Catinazzo Thomas sold 56,323 Common Stock at $16.97 (~$956K)
- · Chief Financial Officer Catinazzo Thomas exercised/converted 61,563 Common Stock at $5.22 (~$321K)
- · Chief Financial Officer Catinazzo Thomas sold 61,563 Common Stock at $16.97 (~$1.04M)
- · Chief Financial Officer Catinazzo Thomas exercised/converted 51,560 Common Stock at $4.45 (~$229K)
- · Chief Financial Officer Catinazzo Thomas sold 51,560 Common Stock at $16.97 (~$875K)
- · Chief Financial Officer Catinazzo Thomas exercised/converted 56,323 Stock Option (Right to Buy)
24-06-2026
10% owner Clarkston Companies, Inc. acquired 1,600 Series D Preferred Stock at $5,000.00 (~$8M). Clarkston Companies, Inc. holds 1,600 shares after the transaction.
- · 10% owner Clarkston Companies, Inc. acquired 1,600 Series D Preferred Stock at $5,000.00 (~$8M)
- · 10% owner Clarkston Companies, Inc. disposed of 1,600 Series C Preferred Stock at $5,000.00 (~$8M)
24-06-2026
WINMILL & CO. INC bought 1,135 Shares of Beneficial Interest at $16.78 (~$19K). WINMILL & CO. INC holds 229,705 shares after the transaction.
- · WINMILL & CO. INC bought 1,135 Shares of Beneficial Interest at $16.78 (~$19K)
- · WINMILL & CO. INC bought 1,000 Shares of Beneficial Interest at $16.81 (~$16.8K)
24-06-2026
SVP of Human Resources Green Paula sold 291 Common Stock at $87.32 (~$25.4K). Green Paula holds 120,414 shares after the transaction.
- · SVP of Human Resources Green Paula sold 291 Common Stock at $87.32 (~$25.4K)
24-06-2026
President, R&D Bergstrom Donald A sold 93,456 Common Stock at $16.94 (~$1.58M). Bergstrom Donald A holds 418,557 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President, R&D Bergstrom Donald A exercised/converted 93,456 Common Stock at $4.12 (~$385K)
- · President, R&D Bergstrom Donald A sold 93,456 Common Stock at $16.94 (~$1.58M)
- · President, R&D Bergstrom Donald A exercised/converted 93,456 Stock Option (Right to Buy)
24-06-2026
See Remarks Cho Dennis sold 346 Common Stock at $87.32 (~$30.2K). Cho Dennis holds 119,346 shares after the transaction.
- · See Remarks Cho Dennis sold 346 Common Stock at $87.32 (~$30.2K)
24-06-2026
Chief Product Officer Gazit Daniel sold 274 Ordinary Shares at $16.70 (~$4.58K). Gazit Daniel holds 2,585 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Product Officer Gazit Daniel sold 274 Ordinary Shares at $16.70 (~$4.58K)
24-06-2026
CHIEF BUSINESS OFFICER Yandell Keith was awarded 37,296 Class A Common Stock. Yandell Keith holds 130,834 shares after the transaction.
- · CHIEF BUSINESS OFFICER Yandell Keith was awarded 37,296 Class A Common Stock
- · CHIEF BUSINESS OFFICER Yandell Keith was awarded 12,432 Class A Common Stock
Get daily alerts with 12 investment signals, 10 risk alerts, 9 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Insider Trading Pulse
🇺🇸 More from United States
View all →June 24, 2026
US Pre-Market SEC Filings Roundup — June 24, 2026
US Pre-Market SEC Filings Roundup
June 24, 2026
Global High-Priority Regulatory Events — June 24, 2026
Global High-Priority Regulatory Events
June 24, 2026
Dow Jones 30 Stocks SEC Filings — June 24, 2026
Dow Jones 30 Stocks SEC Filings
June 24, 2026
US Corporate Distress Financial Stress SEC Filings — June 24, 2026
US Corporate Distress Financial Stress SEC Filings